Hualan Biological Bacterin Inc.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Hualan Biological Vaccine Co., Ltd. was established in 2005 and is a high-tech enterprise engaged in the research, production, and sales of vaccine products. It is the birthplace of the first batch of influenza A (H1N1) vaccines to be launched globally, the fifth enterprise in the world, and the first enterprise in China to pass WHO pre certification for influenza vaccines. The company has fully passed the "ISO" management system certification for quality, environment, and occupational health and safety, and has multiple independent intellectual property rights. Its leading products, with their advantages in production scale, market share, and brand influence, lead the development of the domestic industry. |
| Headquarter | Xinxiang |
| Establish Date | 11/9/2005 |
| Listed Code | 301207.SZ |
| Listed Date | 2/18/2022 |
| Chairman | Ankang. |
| CEO | An Wenjue. |
| Website | www.hualanbacterin.com |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
